About Doublecortin domain-containing protein 2C
Doublecortin domain-containing protein 2C (DCDC2C) is a protein
from Homo sapiens identified by UniProt accession
A8MYV0, 364 residues long.
MolForge cross-references it against 0 known binders and
17 disease associations.
Target properties
| Protein name | Doublecortin domain-containing protein 2C |
| UniProt accession | A8MYV0 |
| Gene | DCDC2C |
| Organism | Homo sapiens |
| Length | 364 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (17)
Diseases linked to this target (Open Targets).
- ceramide measurement · score 0.32
- adolescent idiopathic scoliosis · score 0.17
- methylmalonic aciduria and homocystinuria type cblC · score 0.12
- Methylmalonic acidemia with homocystinuria, type cblC · score 0.12
- Methylmalonic acidemia with homocystinuria · score 0.12
- restless legs syndrome · score 0.11
- dental caries · score 0.09
- autosomal recessive spondylocostal dysostosis · score 0.06
- self reported educational attainment · score 0.06
- cervical spondylosis · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A8MYV0-F1 | alphafold | PREDICTED | 70.43 | — |
Amino-acid sequence (364 residues)
MGTRGPSAPV DTTPAKTIVV YRNGDPFYVG KKFVLSRRRA ATFEALLEQL TEQVDVPFGV RRLFTPTRGH RVLGLDALQA GGKYVAAGRE RFKELDYIHI VPRKPAKIRK LKEIKPVVHC DINVPSKWQT YHRISRHINV FTNGRLFIPP AKIIIPKFSL SDWDIVLATI GEKVFPLGGV RKLFTMNGHL LGDSKDLQDN HFYVAVGLET FKYFPYWKSP RVPSEVQQRY ANVEKNSQRK KKVDSKGKEP CKYDGIPPKT QDSVYYAKEE KKKTLAEPLV QRGAEGDVYK APTPSKETQG ALDVKEEHNV QLEVPVDQRQ AEIVKEDEEI HENTPDFEGN KDKEDARLCE DVERKMAREW KPVD
Explore Doublecortin domain-containing protein 2C with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets